RSS Feed PMR Sponsors News
« Back to listings

Probity Medical Research Expands Clinical Trial Operations to Australia

0
0

Probity Medical Research Inc. (PMR) a leading provider of clinical research support services has expanded clinical research activity by launching operations in Australia.  The move supports the continued development of PMR's dermatology clinical trial group by adding five dermatology sites across Australia. Each facility in Australia has over 10 years of experience in clinical trials for indications such as psoriasis, skin cancer, atopic dermatitis (eczema), acne and other dermatological conditions.

This new partnership expands upon PMR's current operations in Canada and the US. The first clinical trial that has begun at the Australian facilities is for the inflammatory skin disease, Psoriasis.

More information on the Psoriasis clinical trial can be found here: http://www.researchtrials.org/long-term-study-of-daily-oral-tablets-for-psoriasis

 

About Psoriasis

Psoriasis is a non-contagious, inflammatory skin disease that causes red, dry, scaly patches (called lesions) on the skin.  These lesions can make the skin itch, burn, flake, or bleed. The most common form, plaque psoriasis, involves patches of raised, red skin covered with a silvery, white, flaky scale. Between 2 to 3 percent of the worldwide population has Psoriasis. Plaque psoriasis has no known cure.  

 

PMR's Australian Research Affiliates

Melbourne:

Skin & Cancer Foundation in Carlton, Victoria is a not-for-profit, non-government organization which provides specialist treatment for a wide variety of skin diseases. Associate Professor Peter Foley and Associate Professor Chris Baker lead the dermatology clinical trials unit focusing on new therapies for psoriasis, skin cancer, atopic dermatitis and psoriatic arthritis. Since its formation in 1987, The Skin and Cancer Foundation has been at the forefront of developing new and better ways to diagnose and manage the wide range of diseases of the skin.  Founded by a group of 40 leading dermatologists, the Foundation is internationally recognized for its work in dermatology.

 

Sydney:

St. George Dermatology in Kogarah and Central Sydney Dermatology in Sydney are group dermatology practices operated by Dr. Stephen Shumack.  Dr. Shumack is a well known dermatologist in Australia. He has practiced dermatology in Sydney for the past twenty years and has been for many years the principal media spokesperson in Australia for Dermatology. He continues to work closely with the community and his colleagues at Royal North Shore Hospital of Sydney, the Skin and Cancer Foundation, Australia, and Epiderm (Australian Dermatology Research and Education Foundation).

Dr. Shumack and Dr. Adrian Lim have participated in numerous clinical research studies for dermatological conditions including psoriasis, atopic dermatitis, acne and skin cancers. Dr. Shumack and his research team continue to be involved in a number of clinical research trials as part of their ongoing interest in education and diagnostics.

 

Perth:

Fremantle Dermatology is a large dermatology private practice in Western Australia. Clinical Associate Professor Kurt Gebauer has been practicing dermatology for 20 years in Australia and is presently the head of the Department of Dermatology at Fremantle Hospital. Dr. Gebauer participates in clinical research studies in order to offer new and innovative treatments for dermatological conditions including psoriasis, acne, actinic keratoses, onychomycosis, and skin cancer.

Along with his research, Dr. Gebauer can also be found lecturing locally and internationally on different medical topics. As a contributing author on many publications, Dr. Gebauer is a well-known authority on dermatological conditions.

 

Brisbane:

Specialist Connect is a multidisciplinary medical practice located in the heart of Brisbane. Dr. Lynda Spelman, a Dermatologist practicing in Brisbane for over 17 years leads the dermatology clinical research team at Specialist Connect. The site is currently involved in clinical trials in the fields of Atopic Dermatitis/Eczema, Plaque Psoriasis, Seborrheic keratosis and Superficial basal cell carcinoma.  Dr. Spelman also functions as Head of Clinical Services, Queensland Institute of Dermatology, at Greenslopes Private Hospital.

 

About Probity Medical Research Inc.

Probity Medical Research Inc. (PMR) is a clinical research company that trains and provides administrative support for clinical trial sites. Established in 1995 by internationally recognized dermatology and psoriasis researcher Dr. Kim Papp, PMR has grown to include clinical research sites located in the United States, Canada, and Australia. The physicians affiliated with PMR have conducted over 500 clinical research studies involving more than 13,000 patients.

For more information about the Investigators who work with PMR and their experience in clinical research please contact studies@probitymedical.com.

www.probitymedical.com

 

Comments

There are currently no comments.

Log in to post a comment.

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login